Low Frequency of Parental Mosaicism in De Novo COL4A5 Mutations in X-linked Alport Syndrome

Overview

Journal Mol Genet Genomic Med

Specialty Genetics

Date 2020 Aug 20

PMID 32812400

Citations 2

Authors

Ole Magnus Bjorgaas Helle

Torkild Hoieggen Pedersen

Lilian Bomme Ousager

Mads Thomassen

Jens Michael Hertz

Affiliations

Soon will be listed here.

Abstract

Background: Alport syndrome is a progressive hereditary kidney disease clinically presenting with haematuria, proteinuria, and early onset end-stage renal disease, and often accompanied by hearing loss and ocular abnormalities. The inheritance is X-linked in the majority of families and caused by sequence variants in the COL4A5 gene encoding the α5-chain of type-IV collagen. The proportion of de novo COL4A5 sequence variants in X-linked Alport syndrome has been reported between 12 and 15% in previous studies.

Methods: In the present study we have systematically investigated the mosaic status of asymptomatic parents of six patients with X-linked Alport syndrome using next-generation sequencing of DNA extracted from different tissues. The deleterious COL4A5 sequence variants in these patients were previously assumed to be de novo, based on Sanger sequencing of the parents.

Results: A low-grade (1%) parental mosaicism was detected in only one out of six families (17%). In addition, in one out of six families (17%), we found that the mutational event probably occurred postzygotic.

Conclusion: These findings highlight the importance of testing for mosaicism in unaffected parents of patients with sequence variants considered to be de novo, as it may have implications for the recurrence risk and thereby for the genetic counseling of the family.

Citing Articles

Detection of Very Low-Level Somatic Mosaic Splicing Variant in Asymptomatic Female Using Droplet Digital PCR.

Deng H, Zhang Y, Ding J, Wang F Front Med (Lausanne). 2022; 9:847056.

PMID: 35360741 PMC: 8963732. DOI: 10.3389/fmed.2022.847056.

Low frequency of parental mosaicism in de novo COL4A5 mutations in X-linked Alport syndrome.

Helle O, Pedersen T, Ousager L, Thomassen M, Hertz J Mol Genet Genomic Med. 2020; 8(10):e1452.

PMID: 32812400 PMC: 7549549. DOI: 10.1002/mgg3.1452.

References

Girard M, Couvert P, Carrie A, Tardieu M, Chelly J, Beldjord C . Parental origin of de novo MECP2 mutations in Rett syndrome. Eur J Hum Genet. 2001; 9(3):231-6. DOI: 10.1038/sj.ejhg.5200618. View

Hertz J, Juncker I, Persson U, Matthijs G, Schmidtke J, Petersen M . Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome. Hum Mutat. 2001; 18(2):141-8. DOI: 10.1002/humu.1163. View

Hasstedt S, Atkin C . X-linked inheritance of Alport syndrome: family P revisited. Am J Hum Genet. 1983; 35(6):1241-51. PMC: 1685969. View

Acuna-Hidalgo R, Bo T, Kwint M, van de Vorst M, Pinelli M, Veltman J . Post-zygotic Point Mutations Are an Underrecognized Source of De Novo Genomic Variation. Am J Hum Genet. 2015; 97(1):67-74. PMC: 4571017. DOI: 10.1016/j.ajhg.2015.05.008. View

Beicht S, Strobl-Wildemann G, Rath S, Wachter O, Alberer M, Kaminsky E . Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome. Gene. 2013; 526(2):474-7. DOI: 10.1016/j.gene.2013.05.045. View

Krol R, Nozu K, Nakanishi K, Iijima K, Takeshima Y, Fu X . Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome. Nephrol Dial Transplant. 2008; 23(8):2525-30. DOI: 10.1093/ndt/gfn005. View

Pajari H, Kaariainen H, Muhonen T, KOSKIMIES O . Alport's syndrome in 78 patients: epidemiological and clinical study. Acta Paediatr. 1996; 85(11):1300-6. DOI: 10.1111/j.1651-2227.1996.tb13915.x. View

Kong A, Frigge M, Masson G, Besenbacher S, Sulem P, Magnusson G . Rate of de novo mutations and the importance of father's age to disease risk. Nature. 2012; 488(7412):471-5. PMC: 3548427. DOI: 10.1038/nature11396. View

Tazon-Vega B, Ars E, Burset M, Santin S, Ruiz P, Fernandez-Llama P . Genetic testing for X-linked Alport syndrome by direct sequencing of COL4A5 cDNA from hair root RNA samples. Am J Kidney Dis. 2007; 50(2):257.e1-14. DOI: 10.1053/j.ajkd.2007.05.004. View

10.

Crow J . The high spontaneous mutation rate: is it a health risk?. Proc Natl Acad Sci U S A. 1997; 94(16):8380-6. PMC: 33757. DOI: 10.1073/pnas.94.16.8380. View

11.

Lupski J . Genetics. Genome mosaicism--one human, multiple genomes. Science. 2013; 341(6144):358-9. DOI: 10.1126/science.1239503. View

12.

Inoue Y, Nishio H, Shirakawa T, Nakanishi K, Nakamura H, Sumino K . Detection of mutations in the COL4A5 gene in over 90% of male patients with X-linked Alport's syndrome by RT-PCR and direct sequencing. Am J Kidney Dis. 1999; 34(5):854-62. DOI: 10.1016/S0272-6386(99)70042-9. View

13.

Helle O, Pedersen T, Ousager L, Thomassen M, Hertz J . Low frequency of parental mosaicism in de novo COL4A5 mutations in X-linked Alport syndrome. Mol Genet Genomic Med. 2020; 8(10):e1452. PMC: 7549549. DOI: 10.1002/mgg3.1452. View

14.

Daga S, Baldassarri M, Lo Rizzo C, Fallerini C, Imperatore V, Longo I . Urine-derived podocytes-lineage cells: A promising tool for precision medicine in Alport Syndrome. Hum Mutat. 2017; 39(2):302-314. DOI: 10.1002/humu.23364. View

15.

Biesecker L, Spinner N . A genomic view of mosaicism and human disease. Nat Rev Genet. 2013; 14(5):307-20. DOI: 10.1038/nrg3424. View

16.

MARTIN P, Heiskari N, Zhou J, Leinonen A, Tumelius T, Hertz J . High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing. J Am Soc Nephrol. 1998; 9(12):2291-301. DOI: 10.1681/ASN.V9122291. View

17.

Kruegel J, Rubel D, Gross O . Alport syndrome--insights from basic and clinical research. Nat Rev Nephrol. 2012; 9(3):170-8. DOI: 10.1038/nrneph.2012.259. View

18.

Hertz J . Alport syndrome. Molecular genetic aspects. Dan Med Bull. 2009; 56(3):105-52. View

19.

Okamoto T, Nozu K, Iijima K, Ariga T . Germline mosaicism is a pitfall in the diagnosis of "sporadic" X-linked Alport syndrome. J Nephrol. 2018; 32(1):155-159. DOI: 10.1007/s40620-018-0518-y. View

20.

Palenzuela L, Callis L, Vilalta R, Vila A, Nieto J, Meseguer A . A new point mutation in the COL4A5 gene described in a Spanish family with X-linked Alport syndrome. Nephron. 2002; 90(4):455-9. DOI: 10.1159/000054734. View